Avoid reconstitution in buffers containing strong chelators (EDTA, EGTA) or reducing agents (DTT, -mercaptoethanol, TCEP), which can strip the copper from the tripeptide and convert the complex to free GHK
Because this treatment is safe for everyone, it does not have any side effects risks or medical restrictions
In some embodiments, the auris-acceptable penetration enhancer is a surfactant comprising an alkyl-glycoside and/or a saccharide alkyl ester
Bottom line on safety: If someone considers peptide therapy, it should be under medical supervision with pre-treatment screening (baseline GH/IGF-I, metabolic panel, glucose), ongoing monitoring, and sourcing from reputable, traceable suppliers under a lawful framework